Insud Pharma is excited to announce a significant funding round, raising €2,700,000 to further its mission of enhancing global healthcare access. With an established presence across the pharmaceutical value chain—encompassing scientific research, development, manufacturing, and marketing—Insud Pharma operates in multiple regions, including Europe, the Americas, Asia, and Africa. This latest investment will bolster the company’s three key business areas: Industrial (Chemo), Branded (Exeltis), and Biotech (mAbxience). With more than 7,300 dedicated professionals across over 50 countries and cutting-edge facilities, Insud Pharma is uniquely positioned to address the diverse needs of its 1,150 customers in 96 countries. The funds will primarily be directed towards expanding the company’s robust R&D initiatives, helping accelerate the development of innovative therapies that target broader health challenges. This funding aligns with Insud Pharma’s commitment to sustainable development and innovation, ensuring that quality medicines remain accessible and affordable for all. As the company strengthens its manufacturing and commercial networks, it aims to seize global opportunities while continuously improving the health and quality of life for communities worldwide. With a forward-thinking approach, Insud Pharma is poised not just to navigate, but to lead, the ever-evolving landscape of the pharmaceutical industry while keeping patient well-being at the forefront of its endeavors.
INSUD PHARMA Secures $2.7 Million Investment to Propel Global Pharmaceutical Innovation and Development
Recently funded · $2.7MPharmaceutical Industry
Get the full Insud Pharma company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
